NHS Branded Medicines Tranche Framework for London and South of England
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £832,292,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 5 Apr 2024 |
| Procedure | open |
| OCID | ocds-h6vhtk-0445bc |
Awards (60)
This procurement was awarded to 34 suppliers. Values shown are per-award; the notice total is £832,292,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord-UK Ltd shared | £380,950,720 | 21 Jul 2024 | active |
| ACCORD-UK LTD shared | · | · | active |
| AstraZeneca shared | £380,950,720 | 21 Jul 2024 | active |
| AstraZeneca shared | · | · | active |
| Aventis Pharma ltd t/a Sanofi shared | £380,950,720 | 21 Jul 2024 | active |
| Aventis Pharma ltd t/a Sanofi shared | · | · | active |
| Aventis Pharma t/a Sanofi shared | · | · | active |
| Biogen shared | £380,950,720 | 21 Jul 2024 | active |
| Biogen shared | · | · | active |
| BIOSIMILAR COLLABORATIONS IRELAND LIMITED shared | £380,950,720 | 21 Jul 2024 | active |
| BIOSIMILAR COLLABORATIONS IRELAND LIMITED shared | · | · | active |
| Celltrion Healthcare United Kingdom Limited shared | £380,950,720 | 21 Jul 2024 | active |
| Celltrion Healthcare United Kingdom Limited shared | · | · | active |
| Chugai Pharma UK Ltd shared | £380,950,720 | 21 Jul 2024 | active |
| Chugai Pharma UK Ltd shared | · | · | active |
| Dr.Reddy's Laboratories (UK) Limited shared | £380,950,720 | 21 Jul 2024 | active |
| Dr.Reddy's Laboratories (UK) Limited shared | · | · | active |
| Eli Lilly and Company Ltd shared | · | · | active |
| Eli Lilly & Company Ltd shared | £380,950,720 | 21 Jul 2024 | active |
| Galapagos Biotech Ltd shared | £380,950,720 | 21 Jul 2024 | active |
| Galapagos Biotech Ltd shared | · | · | active |
| Gedeon Richter UK Ltd shared | £380,950,720 | 21 Jul 2024 | active |
| Gedeon Richter UK Ltd shared | · | · | active |
| GlaxoSmithKline UK Limited shared | £380,950,720 | 21 Jul 2024 | active |
| GlaxoSmithKline UK Limited shared | · | · | active |
| Janssen-Cilag Ltd shared | £380,950,720 | 21 Jul 2024 | active |
| Janssen-Cilag Ltd shared | · | · | active |
| LEO Pharma shared | £380,950,720 | 21 Jul 2024 | active |
| LEO Pharma shared | · | · | active |
| Manx Healthcare Ltd shared | £380,950,720 | 21 Jul 2024 | active |
| Manx Healthcare Ltd shared | · | · | active |
| Merck Sharpe and Dohme (UK) Limited shared | · | · | active |
| Merck Sharpe & Dohme (UK) Limited shared | £380,950,720 | 21 Jul 2024 | active |
| Napp Pharmaceuticals Ltd shared | £380,950,720 | 21 Jul 2024 | active |
| Napp Pharmaceuticals Ltd shared | · | · | active |
| NOVARTIS PHARMACEUTICALS UK LIMITED shared | · | · | active |
| Novartis Pharmaceuticals UK Ltd shared | £380,950,720 | 21 Jul 2024 | active |
| Novartis Pharmaceuticals UK Ltd shared | · | · | active |
| Organon Pharmaceuticals UK Ltd shared | £380,950,720 | 21 Jul 2024 | active |
| Organon Pharmaceuticals UK Ltd shared | · | · | active |
| Orifarm UK shared | £380,950,720 | 21 Jul 2024 | active |
| Orifarm UK shared | · | · | active |
| Pfizer Ltd shared | £380,950,720 | 21 Jul 2024 | active |
| Pfizer Ltd shared | · | · | active |
| Roche Products Ltd shared | £380,950,720 | 21 Jul 2024 | active |
| Roche Products Ltd shared | · | · | active |
| Sobi (Swedish Orphan Biovitrum Ltd) shared | £380,950,720 | 21 Jul 2024 | active |
| Sobi (Swedish Orphan Biovitrum Ltd) shared | · | · | active |
| Sun Pharma UK Ltd shared | £380,950,720 | 21 Jul 2024 | active |
| Sun Pharma UK Ltd shared | · | · | active |
| Takeda UK Ltd shared | £380,950,720 | 21 Jul 2024 | active |
| Takeda UK Ltd shared | · | · | active |
| Teva UK Limited shared | £380,950,720 | 21 Jul 2024 | active |
| Teva UK Limited shared | · | · | active |
| Thornton and Ross Ltd shared | £380,950,720 | 21 Jul 2024 | active |
| Thornton and Ross Ltd shared | · | · | active |
| UCB Pharma Ltd (primary) shared | £380,950,720 | 21 Jul 2024 | active |
| UCB Pharma Ltd (primary) shared | · | · | active |
| Zentiva Pharma UK Ltd shared | £380,950,720 | 21 Jul 2024 | active |
| Zentiva Pharma UK Ltd shared | · | · | active |
description
NHS Branded Medicines Tranche Framework for London and South of England - 1 September 2024<br/>Offer reference number: CM/PHR/22/5689<br/>CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South of England Tranche A. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.<br/>CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South of England Tranche B. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.<br/>CM/PHR/22/5689/03 - NHS Framework for the supply of Omalizumab and Diroximel Fumarate for the Midlands & East and North of England. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
documents
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/12d49df7-2728-4fef-88da-b0005136eda4
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/427341ce-0997-46c7-b23b-e0cbabf30a14
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/47384f7d-1323-4f27-889d-e75454f9ea4e
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/572c6757-6889-4eb5-83a8-72a8dec7c878
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/5d957f91-4ed8-48a7-b222-b6f13e3968b8
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/5ffa699a-7898-4f2e-88d1-f4de430639f2
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/8fbbd800-c320-4d3b-8a29-9f03a0d7f54d
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/948a0dc8-61ad-466c-98d8-6e95f03ab74c
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/96854b0e-b75d-4bfa-9341-3148ec0c4206
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/9f3a671f-8544-42f0-a107-93d61e1f6691
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/ae8213c4-a7ee-4ceb-8957-4abb0c92fef5
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/c202d9a8-4097-4b81-b566-78e9efba4d6a
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/c5264e86-a81d-47dd-8307-09c0d2d28ccc
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/c7f6e9bc-f39d-4f0d-910d-7bd662c5ddd7
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/d6f59ab5-8535-4e24-964d-0cbc288c5b6e
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/e4290bc2-82e0-43c5-a386-dbd6dd51dd5a
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/e8f06b21-3104-49e8-8561-9e7e344f13f2
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/f3a7c723-a497-401c-a237-98e5848b2f83
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/f5d4869c-9337-4483-bb97-5492d00c6abf
- https://www.contractsfinder.service.gov.uk/Notice/ec04b0c1-fa5f-4f72-b22d-4dc3210e80b9 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
4 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 5 Mar 2024 | Contract notice (F02) | Earlier regulations | 007069-2024 |
| 5 Mar 2024 | Tender (tender) | · | ec04b0c1-fa5f-4f72-b22d-4dc3210e80b9-729241 |
| 20 Aug 2024 | Contract award notice (F03) | Earlier regulations | 026491-2024 |
| 20 Aug 2024 | Award (award) | · | 5804a973-6494-40b3-8ef1-7809f1927694-778994 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.